{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:15Z","timestamp":1761100995126},"reference-count":264,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.4065\/74.1.78","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:16:10Z","timestamp":1232759770000},"page":"78-100","source":"Crossref","is-referenced-by-count":87,"title":["Antifungal Agents. Part II. The Azoles"],"prefix":"10.4065","volume":"74","author":[{"given":"Christine L.","family":"Terrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/74.1.78_bib1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.17.6.922","article-title":"In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis","volume":"17","author":"Van den Boaache","year":"1980","journal-title":"Antimivrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/jac\/6.4.552","article-title":"The influence of gastric acidity on the bio-availability of ketoconazole [letter]","volume":"6","author":"Van Der Meer","year":"1980","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.1.78_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-109-6-471","article-title":"Gastropathy and ketoconazole mal absorption in the acquired immunodeficiency syndrome (AIDS)","volume":"109","author":"Lake-Bakaar","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib4","first-page":"866","article-title":"Modification of gastric pH with oral glutamic acid hydrochloride","volume":"10","author":"Knapp","year":"1991","journal-title":"Clin Pharm"},{"key":"10.4065\/74.1.78_bib5","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1128\/AAC.39.8.1671","article-title":"Effects of an acidic beverage (Coca-Cola) on absorption ot ketoconazole","volume":"39","author":"Chin","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib6","series-title":"Principles and Practice of Infectious Diseases","first-page":"361","article-title":"Antifungal agents","author":"Bennett","year":"1990"},{"key":"10.4065\/74.1.78_bib7","first-page":"101","article-title":"Interaction of ketoconazole and sucralfate in healthy volunteers [abstract]","volume":"11","author":"Carver","year":"1991","journal-title":"Pharmacotherapy"},{"key":"10.4065\/74.1.78_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/AAC.19.1.110","article-title":"Liquid Chromatographic assay of ketoconazole","volume":"19","author":"Andrews","year":"1981","journal-title":"Antimicrob Agents Cnemother"},{"key":"10.4065\/74.1.78_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/clinids\/2.4.661","article-title":"Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients","volume":"2","author":"Graybill","year":"1980","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib10","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/AAC.31.12.1874","article-title":"Pharmacology and toxicity of high-dose ketoconazole","volume":"31","author":"Sugar","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/AAC.21.1.151","article-title":"Disposition of ketoconazole. an oral antifungal, in humans","volume":"21","author":"Brass","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198223010-00001","article-title":"Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections","volume":"23","author":"Heel","year":"1982","journal-title":"Drugs"},{"key":"10.4065\/74.1.78_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0003-4819-103-6-861","article-title":"Treatment of blastomycosis and histoplasmosis with ketoconazole: results of a prospective randomized clinical trial","volume":"103","author":"National Institute of Allergy and Infectious Diseases Mycoses Study Group","year":"1985","journal-title":"Ann intern Med"},{"issue":"Suppl lB","key":"10.4065\/74.1.78_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0002-9343(83)90517-X","article-title":"Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole","volume":"74","author":"Slama","year":"1983","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005792-199011000-00004","article-title":"Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature","volume":"69","author":"Wheat","year":"1990","journal-title":"Medicine"},{"key":"10.4065\/74.1.78_bib16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.7326\/0003-4819-103-6-872","article-title":"Ketoconazole therapy for endemic blastomycosis","volume":"103","author":"Bradsher","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1378\/chest.93.4.848","article-title":"Treatment of histoplasmosis and blastomycosis","volume":"93","author":"Saag","year":"1988","journal-title":"Chest"},{"key":"10.4065\/74.1.78_bib18","first-page":"261","article-title":"Ketoconazole treatment of Candida esophagitis-a prospective study of 12 cases","volume":"78","author":"Fazio","year":"1983","journal-title":"Am J Gastroenterol"},{"key":"10.4065\/74.1.78_bib19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/clinids\/2.4.674","article-title":"An evaluation of two years of clinical experience with ketoconazole","volume":"2","author":"Symoens","year":"1980","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/clinids\/2.4.606","article-title":"Chronic mucocutaneous candidosis and other superficial and systemic mycoses successfully treated with ketoconazole","volume":"2","author":"Drouhet","year":"1980","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/clinids\/24.2.124","article-title":"Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans","volume":"24","author":"Laguna","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0002-9343(88)90143-X","article-title":"Ketoconazole therapy of progressive coccidioidomycosis: comparison of 400- and 800-mg doses and observations at higher doses","volume":"84","author":"Galgiani","year":"1988","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/clinids\/2.4.643","article-title":"Ketoconazole in the treatment of paracoccidioidomycosis and histoplasmosis","volume":"2","author":"Negroni","year":"1980","journal-title":"Rev Infect Dis"},{"issue":"Suppl lB","key":"10.4065\/74.1.78_bib24","first-page":"48","article-title":"Treatment of paracoccidioidomycosis with ketoconazole: a three-year experience","volume":"74","author":"Restrepo","year":"1983","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib25","first-page":"155","article-title":"Evatuacion a largo plazo de pacientes con paracoccidioidomycosis tratados con ketoconazol","volume":"10","author":"Robledo","year":"1985","journal-title":"Acta Med Colombiani"},{"key":"10.4065\/74.1.78_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.86.2.219","article-title":"Pseudailescheria boydii infections treated with ketoconazole: clinical evaluations of seven patients and in vitro susceptibility results","volume":"86","author":"Galglanf","year":"1984","journal-title":"Chest"},{"key":"10.4065\/74.1.78_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-98-1-13","article-title":"Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients; National Institute of Allergy and Infectious Diseases Collaborative Antifungal Study","volume":"98","author":"Dismukes","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/clinids\/13.1.47","article-title":"Treatment of systemic sporotrichosis with ketoconazole","volume":"13","author":"Calhoun","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib29","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1001\/jama.1982.03320490047035","article-title":"Failure of ketoconazole in cryptococcal meningitis","volume":"247","author":"Perfect","year":"1982","journal-title":"JAMA"},{"issue":"Suppl lB","key":"10.4065\/74.1.78_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0002-9343(83)90512-0","article-title":"Laboratory and clinical assessment of ketoconazole in deep-seated mycoses","volume":"74","author":"Drouhet","year":"1983","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0016-5085(84)80021-9","article-title":"Hepatic injury associated with ketoconazole therapy: analysis of 33 cases","volume":"86","author":"Lewis","year":"1984","journal-title":"Gastro-enterology"},{"key":"10.4065\/74.1.78_bib32","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1177\/106002809402801009","article-title":"Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity","volume":"28","author":"Gearhart","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.1.78_bib33","first-page":"520A","article-title":"Ketoconazole inhibits adrenal steroid synthesis (abstract]","volume":"30","author":"Pont","year":"1982","journal-title":"Clin Res"},{"key":"10.4065\/74.1.78_bib34","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-97-3-370","article-title":"Ketoconazole blocks adrenal steroid synthesis","volume":"97","author":"Pont","year":"1982","journal-title":"Ann Intern Med"},{"issue":"Suppl 6","key":"10.4065\/74.1.78_bib35","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1097\/00004872-198900076-00102","article-title":"Arterial hypertension as a complication of prolonged ketoconazole treatment","volume":"7","author":"Leal-Cerro","year":"1989","journal-title":"J Hypertens"},{"key":"10.4065\/74.1.78_bib36","first-page":"6163","article-title":"Safety of antimicrobial drugs in pregnancy","volume":"29","year":"1987","journal-title":"Med Lett Drugs Ther"},{"key":"10.4065\/74.1.78_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00007890-198402000-00020","article-title":"Cyclosporine and ketoconazole","volume":"37","author":"White","year":"1984","journal-title":"Transplantation"},{"key":"10.4065\/74.1.78_bib38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/bmj.288.6412.188-a","article-title":"Potentiation of oral anticoagulants by ketoconazole","volume":"288","author":"Smith","year":"1984","journal-title":"BMJ"},{"key":"10.4065\/74.1.78_bib39","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/clpt.1986.114","article-title":"Effects of ketoconazole on methylprednisolone pharmacokinetics and Cortisol secretion","volume":"39","author":"Glynn","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/74.1.78_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/clpt.1994.60","article-title":"Midazoiam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole","volume":"55","author":"Olkkola","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/74.1.78_bib41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/clpt.1994.184","article-title":"Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole","volume":"56","author":"Varhe","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/74.1.78_bib42","series-title":"Xanax (brand of alprazolam tablets, USP) [package insert]","year":"1996"},{"key":"10.4065\/74.1.78_bib43","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1001\/jama.1990.03450210088038","article-title":"Torsades de pointes occurring in association wi\u00fci terfenadine use","volume":"264","author":"Mnnahan","year":"1990","journal-title":"JAMA"},{"key":"10.4065\/74.1.78_bib44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-114-9-755","article-title":"Increased gastric pH and the bioavailability of fluconazole and ketoconazole","volume":"114","author":"Blum","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00199879","article-title":"Influence of concomitant food intake on the oral absorption of two triazoee antifungal agents, itraconazale and fluconazole","volume":"46","author":"Zimmermann","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 3","key":"10.4065\/74.1.78_bib46","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1093\/clinids\/12.Supplement_3.S318","article-title":"Pharmacokinetics and tissue penetration of fluconazole in humans","volume":"12","author":"Brammer","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib47","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(89)92572-5","article-title":"Comparison of fluconazole and ketoconazoee for oropharyngeal candidiasis in AIDS","volume":"1","author":"De Wit","year":"1989","journal-title":"Lancet"},{"key":"10.4065\/74.1.78_bib48","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/clind\/15.4.701","article-title":"Biliary concentrations of fluconazole in a patient with candidal cholecystitis: case report","volume":"15","author":"Bozzette","year":"1992","journal-title":"can Infect Dis"},{"key":"10.4065\/74.1.78_bib49","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1128\/AAC.39.5.1154","article-title":"Puconazole penetration in cerebral parenchyma in humans at steady state","volume":"39","author":"Thaler","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.39.2.553","article-title":"Fluconazoie penetration into the human prostate","volume":"39","author":"Flntey","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib51","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/AAC.40.8.1935","article-title":"Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules","volume":"40","author":"Koks","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.32.3.369","article-title":"Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis","volume":"32","author":"Tucker","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/infdis\/157.1.178","article-title":"Fluconazoie penetration into cerebrospinal fluid; implications for treating fungal infections of the central nervous system","volume":"157","author":"Arndt","year":"1988","journal-title":"J Infect Dis"},{"key":"10.4065\/74.1.78_bib54","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/AAC.28.5.648","article-title":"Pharmacokinetic evaluation of UK49,858, a metabolically stable triazole antifungal drug, in animals and humans","volume":"28","author":"Humphrey","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF01964056","article-title":"New antifungal agents","volume":"8","author":"Graybill","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.1.78_bib56","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Proposed Standard","author":"National Committee for Clinical Laboratory Standards","year":"1995"},{"key":"10.4065\/74.1.78_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","article-title":"Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole. and Candida infections","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib58","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/JCM.34.3.489-495.1996","article-title":"Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome","volume":"34","author":"Ghannoum","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.4065\/74.1.78_bib59","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/clinids\/24.5.776","article-title":"Antifungal susceptibility testing: technical advances and potential clinical applications","volume":"24","author":"Pfaller","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib60","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.34.11.2267","article-title":"Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus","volume":"34","author":"Koletar","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib61","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/infdis\/159.4.806","article-title":"Single dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study","volume":"159","author":"Chave","year":"1989","journal-title":"J Infect Dis"},{"key":"10.4065\/74.1.78_bib62","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/infdis\/174.4.821","article-title":"Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients","volume":"174","author":"Revankar","year":"1996","journal-title":"J Infect Dis"},{"key":"10.4065\/74.1.78_bib63","doi-asserted-by":"crossref","unstructured":"Revankar SG, Dib OP, Kirkpatrick WR, McAtee RK, Fothergill AW, Rinaldi MG, et al. Clinical evaluation and microbiology of fluconazole resistant oropharyngeal candidiasis [abstract]. In: Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections; 1997 Jan 22-26; Washington (DC), p 124","DOI":"10.1086\/513950"},{"key":"10.4065\/74.1.78_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0163-4453(90)90646-P","article-title":"Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS reiated complex: a double-blind placebo-controlled study","volume":"21","author":"Lean","year":"1990","journal-title":"J Infect"},{"key":"10.4065\/74.1.78_bib65","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/jac\/28.6.937","article-title":"Fluconazoie resistance in AIDS patients [letter)","volume":"28","author":"Willock","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.1.78_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.39.1.1","article-title":"Resistance of Candida species to fluconazole","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/infdis\/173.1.219","article-title":"Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients","volume":"173","author":"Maenza","year":"1996","journal-title":"J infect Dis"},{"key":"10.4065\/74.1.78_bib68","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00002030-199405000-00023","article-title":"Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients [letter]","volume":"8","author":"Vuffray","year":"1994","journal-title":"AIDS"},{"key":"10.4065\/74.1.78_bib69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.7326\/0003-4819-126-4-199702150-00020","article-title":"Fluconazoie suspension for oropharyngeal candidiasis unresponsive to tablets [letter]","volume":"126","author":"Martins","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib70","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-117-8-655","article-title":"Fluconazoie compared with ketoconazole for the treatment of Candida esophagitis in AIDS: a randomized trial","volume":"117","author":"Laine","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib71","first-page":"299","article-title":"Fluconazoie (FLU) vs amphotericin B (AMB) treatment of esophageal candidiasis in adults with malignancy [abstract]","volume":"30","author":"Lake-Lewin","year":"1990","journal-title":"Program Abstr intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib72","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1749-6632.1988.tb40452.x","article-title":"Single-dose oral fluconazole in the treatment of vaginal candidosis","volume":"544","author":"Brammer","year":"1988","journal-title":"Ann W Y Acad Sci"},{"key":"10.4065\/74.1.78_bib73","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2165\/00003495-199549060-00009","article-title":"Fluconazoie: an update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis","volume":"49","author":"Perry","year":"1995","journal-title":"Drugs"},{"key":"10.4065\/74.1.78_bib74","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2133.1988.tb03483.x","article-title":"Fluconazoie in the management of patients with chronic mucocutaneous candidosis [letter]","volume":"119","author":"Hay","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.4065\/74.1.78_bib75","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0002-9343(89)90481-6","article-title":"Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent","volume":"86","author":"Levine","year":"1989","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"10.4065\/74.1.78_bib76","first-page":"S357","article-title":"The use of fluconazole in the management of Candida peritonitis in patients on peritoneal dialysis","volume":"13","author":"Hoch","year":"1993","journal-title":"Pent Dirit Int"},{"key":"10.4065\/74.1.78_bib77","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/ndt\/9.5.539","article-title":"Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients","volume":"9","author":"Chan","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.4065\/74.1.78_bib78","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-9394(14)71234-6","article-title":"Treatment of ocular fungal infections with oral fluconazole","volume":"119","author":"Luttrull","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.4065\/74.1.78_bib79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/clinids\/20.3.657","article-title":"Use of fluconazole in the treatment of candidal endopnthaimitis","volume":"20","author":"Akler","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/514504","article-title":"International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections","volume":"25","author":"Edwards","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib81","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF01739908","article-title":"Fluconazoie in the management of fungal urinary tract infections","volume":"22","author":"Voss","year":"1994","journal-title":"Infection"},{"key":"10.4065\/74.1.78_bib82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/clinids\/20.1.183","article-title":"Yeast in the urine: solutions for a budding problem","volume":"20","author":"Fisher","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib83","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/clinids\/22.1.30","article-title":"Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients","volume":"22","author":"Jacobs","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib84","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/clinids\/21.4.960","article-title":"Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria","volume":"21","author":"Fan-Havard","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9343(91)90005-I","article-title":"Hepatosplenic candidiasis: successful treatment with fluconazole","volume":"91","author":"Kauffman","year":"1991","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9343(91)90006-J","article-title":"Fluconazoie therapy for chronic disseminated candidiasis in patients with leukemia and pnor amphotericin B therapy","volume":"91","author":"Analssie","year":"1991","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib87","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/clind\/15.3.414","article-title":"Candidemia in a tertiary care hospital; epidemiology, risk factors, and predictors of mortality","volume":"16","author":"Fraser","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib88","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/clind\/15.3.422","article-title":"Should all patients with candidemia be treated with antifungal agents? [editorial]","volume":"15","author":"Edwards","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib89","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/archinte.1995.00430220087009","article-title":"Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective observational study","volume":"155","author":"Nguyen","year":"1995","journal-title":"Arch fntern Med"},{"key":"10.4065\/74.1.78_bib90","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"10.4065\/74.1.78_bib91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0002-9343(96)80072-6","article-title":"Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study","volume":"101","author":"Anaissle","year":"1996","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib92","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/clinids\/23.5.964","article-title":"Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature","volume":"23","author":"Anaissie","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.39.1.40","article-title":"Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib94","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/clinids\/14.4.875","article-title":"Vascular catheter-associated fungemia in patients with cancer: anaiysis of 155 episodes","volume":"14","author":"Lecciones","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.4065\/74.1.78_bib95","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/clinids\/22.Supplement_2.S95","article-title":"Problems and controversies in the management of hematogenous candidiasis","volume":"22","author":"Uzun","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib96","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.4065\/74.1.78_bib97","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(95)00010-0","article-title":"The changing face of candidemia: emergence of non-Candida albicans species and antilungal resistance","volume":"100","author":"Nguyen","year":"1996","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib98","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-103-4-533","article-title":"Cryptococcosis in the acquired immunodeficiency syndrome","volume":"103","author":"Kovacs","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib99","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-104-2-234","article-title":"Cryptococ-cal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment","volume":"104","author":"Zuger","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-assoo'ated cryptococcal meningitis","volume":"326","author":"Saag","year":"1992","journal-title":"N Engl J Med"},{"key":"10.4065\/74.1.78_bib102","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment Of cryptococcal meningitis associated with the acquired immunodeficiency syndrome","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/74.1.78_bib103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/clinids\/20.2.263","article-title":"Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period","volume":"20","author":"de Lalla","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib104","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/clinids\/19.4.741","article-title":"Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS","volume":"19","author":"Larsen","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib105","unstructured":"Milefchik E, Leal M, Haubrich R, Bozzette S, Tilles J, Leedom J, et al. A phase II dose escalation trial of high dose fluconazole with and without flucytosine for AIDS associated cryptococcal meningitis [abstract]. In: Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections; 1997 Jan 22-26: Washington (DC), p 65"},{"issue":"Suppl 2","key":"10.4065\/74.1.78_bib106","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1093\/clinids\/22.Supplement_2.S119","article-title":"Recent advances in the management of cryptococcal meningitis in patients with AIDS","volume":"22","author":"Powderly","year":"1996","journal-title":"Clin infect Dis"},{"issue":"Suppl 2","key":"10.4065\/74.1.78_bib107","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1093\/clinids\/22.Supplement_2.S148","article-title":"Role of azoles in antifungal therapy","volume":"22","author":"Kauffman","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib108","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199203193261203","article-title":"A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome","volume":"326","author":"Powderly","year":"1992","journal-title":"N Engl J Med"},{"key":"10.4065\/74.1.78_bib109","unstructured":"Pappas PG, Hamill RG, Kauffman CA, Bradsher RW, McKlnsey DS, Cloud GW, et al (NIAID Mycoses Study Group). Treatment of cryptococcal meningitis in non-HIV infected patients-a randomized comparative trial (abstract). Program and Abstracts of the infectious Diseases Society of America 34th Annual Meeting. 1996 Sep 19-22: New Orleans, p 873"},{"issue":"Suppl 2","key":"10.4065\/74.1.78_bib110","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/22.Supplement_2.S154","article-title":"Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus negative patients: retrospective analysis of 83 cases","volume":"22","author":"Dromer","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib111","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00002030-199405000-00011","article-title":"The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection","volume":"8","author":"Nelson","year":"1994","journal-title":"AIDS"},{"key":"10.4065\/74.1.78_bib112","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/clinids\/21.3.628","article-title":"Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS","volume":"21","author":"Meyohas","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib113","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-119-1-199307010-00005","article-title":"Fluconazole therapy for coccidioidal meningitis","volume":"119","author":"Gaigiani","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib114","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-124-3-199602010-00004","article-title":"Is it ever safe to stop azole therapy for Cocddioides immitis meningitis?","volume":"124","author":"Dewsnup","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib115","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archinte.1995.00430150157016","article-title":"Fluconazole therapy in coccidioidal meningitis maintained with intrathecal amphotericin B","volume":"155","author":"Perez","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.1.78_bib116","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80371-4","article-title":"Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis","volume":"98","author":"Catanzaro","year":"1995","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib117","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9343(97)00151-4","article-title":"Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome","volume":"103","author":"Wheat","year":"1997","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib118","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/0003-4819-118-8-199304150-00006","article-title":"Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome","volume":"118","author":"Wheat","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib119","first-page":"241","article-title":"Itraconazole maintenance treatment for histoplasmosis in AIDS: prospective multi-center trial [abstract]","volume":"35","author":"Hecht","year":"1995","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib120","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/clinids\/14.Supplement_1.S68","article-title":"A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host","volume":"14","author":"Diaz","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib121","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/clinids\/23.5.996","article-title":"Fluconazole therapy for histoplasmosis","volume":"23","author":"McKinsey","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1439-0507.1989.tb02219.x","article-title":"Itraconazole in human histoplasmosis","volume":"32","author":"Negroni","year":"1989","journal-title":"Mycoses"},{"key":"10.4065\/74.1.78_bib123","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0002-9343(92)90575-V","article-title":"Itraconazole therapy for blastomycosis and histoplasmosis","volume":"93","author":"Dismukes","year":"1992","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib124","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/clinids\/20.2.267","article-title":"Treatment of blastomycosis with fluconazole: a pilot study","volume":"20","author":"Pappas","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1086\/514539","article-title":"Treatment of blastomycosis with higher doses of fluconazole","volume":"25","author":"Pappas","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/clinids\/22.1.46","article-title":"Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole","volume":"22","author":"Kauffman","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib127","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0002-9343(93)90280-3","article-title":"Treatment of sporotrichosis with itraconazole","volume":"95","author":"Sharkey-Mathis","year":"1993","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib128","first-page":"182","article-title":"Fluconazole therapy in cutaneous and lymphangitic sporotrichosis [abstract]","volume":"30","author":"Montero-Gei","year":"1990","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"issue":"Suppl","key":"10.4065\/74.1.78_bib129","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0190-9622(08)81277-7","article-title":"Treatment of tropical mycoses","volume":"31","author":"Restrepo","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/74.1.78_bib130","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/clind\/15.5.781","article-title":"Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review","volume":"15","author":"Anaissie","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib131","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/172.2.599","article-title":"Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections","volume":"172","author":"Anaissie","year":"1995","journal-title":"J Infect Dis"},{"key":"10.4065\/74.1.78_bib132","doi-asserted-by":"crossref","first-page":"845851","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.4065\/74.1.78_bib133","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.4065\/74.1.78_bib134","first-page":"919","article-title":"Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation","volume":"14","author":"Alangaden","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.4065\/74.1.78_bib135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02026116","article-title":"Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients","volume":"13","author":"Elis","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.1.78_bib136","unstructured":"Winston DJ, Pakrasl A, Busuttll RW. Fluconazole prophylaxis of fungal infections in liver transplant recipients: results of a placebo-controlled, double-blind trial [abstract]. Presented at the Ninth International Symposium on Infections in the Immunocompromised Host: 1996 Jun 23 26: Assis (Italy)"},{"key":"10.4065\/74.1.78_bib137","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/infdis\/174.3.583","article-title":"Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation","volume":"174","author":"Lumbreras","year":"1996","journal-title":"J Infect Dis"},{"key":"10.4065\/74.1.78_bib138","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized placebo-controlled, double-blind, mullicenter trial","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib139","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","article-title":"Association of Torulopsis gtabrata infections with fluconazole prophy-Iaxis in neutropenic bone marrow transplant patients","volume":"37","author":"Wlngard","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib140","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199503163321102","article-title":"A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection","volume":"332","author":"Powderly","year":"1995","journal-title":"N Engl J Med"},{"key":"10.4065\/74.1.78_bib141","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/clinids\/23.6.1282","article-title":"Low-dose fluconazole as primary prophylaxis for crypto coccal infection in AIDS patients with CD4 cell counts of 100\/mm3: demonstration of efficacy in a prospective, multicenter trial","volume":"23","author":"Singh","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib142","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archinte.1997.00440220068009","article-title":"Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection","volume":"157","author":"Manfredi","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.1.78_bib143","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-126-9-199705010-00003","article-title":"Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection: a randomized, double-blind, placebo-controlled trial","volume":"126","author":"Schuman","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib144","first-page":"27","article-title":"Antifungal prophylaxis in AIDS: should it be the standard of care?","volume":"6","author":"Wheat","year":"1994","journal-title":"AIDS Clin Care"},{"key":"10.4065\/74.1.78_bib145","unstructured":"Clancy CJ, Berg J, Nguyen MH. Emergence of fluconazole resistance in C. neoformans: the hidden danger of primary fluconazole prophylaxis in HIV-infected patients [abstract]. In: Program and Abstracts of the Infectious Diseases Society of America 35th Annual Meeting; 1997 Sep 13-16: San Francisco, p 170"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib146","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/clinids\/21.Supplement_1.S32","article-title":"USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease specific recommendations","volume":"21","author":"USPHS\/IDSA Prevention of Opportunistic infections Working Group","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib147","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00003495-199039060-00006","article-title":"Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses","volume":"39","author":"Grant","year":"1990","journal-title":"Drugs"},{"key":"10.4065\/74.1.78_bib148","series-title":"Diflucan (fluconazole) [package insert]","year":"1994"},{"key":"10.4065\/74.1.78_bib149","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-123-5-199509010-00006","article-title":"Alopecia associated with fluconazole therapy","volume":"123","author":"Pappas","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/clinids\/22.2.336","article-title":"Fluconazole-induced congenital anomalies in three infants","volume":"22","author":"Pursley","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib151","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-124-6-199603150-00006","article-title":"Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients","volume":"124","author":"Trapnell","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib152","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.298.6683.1315-b","article-title":"Fluconazole and phenytoin: a predictable interaction","volume":"298","author":"Mitchell","year":"1989","journal-title":"BMJ"},{"key":"10.4065\/74.1.78_bib153","unstructured":"Lazar JD, Wllner KD. Key drug interaction studies with fluconazole [abstract]. 1989 Aug 19-23; Vancouver, British Columbia (Canada)"},{"key":"10.4065\/74.1.78_bib154","first-page":"178","article-title":"Fluconazole in the treatment of candidal prosthetic valve endocarditis","volume":"297","author":"Isalska","year":"1988","journal-title":"8MJ"},{"issue":"Suppl 3","key":"10.4065\/74.1.78_bib155","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1093\/clinids\/12.Supplement_3.S327","article-title":"Drug interactions with fluconazole","volume":"12","author":"Lazar","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib156","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(89)90343-7","article-title":"Interaction of fluconazole with cyclosporin [letter]","volume":"2","author":"Ehninger","year":"1989","journal-title":"Lancet"},{"key":"10.4065\/74.1.78_bib157","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7326\/0003-4819-110-10-844_1","article-title":"Interaction of fluconazole and cyclosporine [letter]","volume":"110","author":"Sugar","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib158","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(89)92353-2","article-title":"Interaction of fluconazole with cyclosporin [letter]","volume":"1","author":"Collignon","year":"1989","journal-title":"Lancet"},{"key":"10.4065\/74.1.78_bib159","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/infdis\/169.5.1103","article-title":"Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus","volume":"169","author":"Sahai","year":"1994","journal-title":"J Infect Dis"},{"key":"10.4065\/74.1.78_bib160","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/jac\/21.5.633","article-title":"Pharmacokinetic study of the interaction between rifampicin and ketoconazole","volume":"21","author":"Doble","year":"1988","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl","key":"10.4065\/74.1.78_bib161","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0190-9622(08)81276-5","article-title":"Antifungal therapy: potential interactions with other classes of drugs","volume":"31","author":"Bickers","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/74.1.78_bib162","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/AAC.37.4.778","article-title":"Food interaction and steady-state pharmacokinetics of itraconazole capsules in nealthy male volunteers","volume":"37","author":"Barone","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib163","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.32.9.1310","article-title":"Pharmacokinetics of itraconazole following oral administration to normal volunteers","volume":"32","author":"Hardin","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib164","first-page":"S94","article-title":"Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopema: preliminary results of two nonrandomized studies","volume":"9","author":"Tricot","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib165","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-9343(89)90475-0","article-title":"Treatment of invasive aspergillosis with itraconazole","volume":"86","author":"Denning","year":"1989","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib166","first-page":"10","article-title":"Systemic antifungal drugs","volume":"38","year":"1996","journal-title":"Med Lett Drugs Ther"},{"key":"10.4065\/74.1.78_bib167","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.2042-7158.1992.tb05478.x","article-title":"The pharmacokinetics of oral itraconazole in AIDS patients","volume":"44","author":"Smith","year":"1992","journal-title":"J Pharm Pharmacol"},{"key":"10.4065\/74.1.78_bib168","first-page":"6","article-title":"The effect of co-administration of a cola beverage on the bioavailability of itraconazole in AIDS patients [abstract]","volume":"35","author":"Hardin","year":"1995","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib169","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199401273300407","article-title":"Oral azole drugs as systemic antifungal therapy","volume":"330","author":"Como","year":"1994","journal-title":"N Engl J Med"},{"key":"10.4065\/74.1.78_bib170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/16.1.81","article-title":"Penetration of imidazoles and tri azoles into cerebrospinal fluid of rabbits","volume":"16","author":"Perfect","year":"1985","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl l","key":"10.4065\/74.1.78_bib171","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1439-0507.1989.tb02296.x","article-title":"The clinical pharmacokinetics of itraconazole: an overview","volume":"32","author":"Heykants","year":"1989","journal-title":"Mycoses"},{"key":"10.4065\/74.1.78_bib172","first-page":"50","article-title":"Pharmacokinetics of oral anti-fungals and their clinical implications","volume":"71","author":"Heykants","year":"1990","journal-title":"Br J Clin Pract Symp Suppl"},{"key":"10.4065\/74.1.78_bib173","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF01962595","article-title":"Treatment of systemic fungal infections: recent progress and current problems","volume":"7","author":"Walsh","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.1.78_bib174","series-title":"Sporanox (itraconazole capsules) [package insert]","year":"1996"},{"key":"10.4065\/74.1.78_bib175","series-title":"Sporanox (itraconazole oral solution) [package insert]","year":"1997"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib176","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1093\/clinids\/9.Supplement_1.S146","article-title":"Itraconazole in the treatment of human mycoses: review of three years of clinical experience","volume":"9","author":"Cauwenbergh","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib177","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/clinids\/23.2.305","article-title":"Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy","volume":"23","author":"Elewski","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib178","first-page":"413417","article-title":"Itraconazole therapy in lymphangitic and cutaneous sporotrichosis","volume":"122","author":"Restrepo","year":"1966","journal-title":"Arch Dermatol"},{"key":"10.4065\/74.1.78_bib179","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1439-0507.1992.tb00836.x","article-title":"Treatment of human cutaneous sporotrichosis with itraconazole","volume":"35","author":"Conti Diaz","year":"1992","journal-title":"Mycoses"},{"key":"10.4065\/74.1.78_bib180","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/clinids\/17.2.210","article-title":"Systemic sporotrichosis treated with itraconazole","volume":"17","author":"Wlnn","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib181","first-page":"1279","article-title":"Fungernia caused by an amphotericin 8-resistant isolate of Sporothrix schenckii: successful treatment with itraconazole","volume":"113","author":"Baker","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"10.4065\/74.1.78_bib182","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/00002030-199110000-00014","article-title":"Disseminated sporotrichosis in patients with AIDS: case report and review of the literature","volume":"5","author":"Heiter","year":"1991","journal-title":"AIDS"},{"key":"10.4065\/74.1.78_bib183","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF01971316","article-title":"Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis","volume":"13","author":"Bolao","year":"1994","journal-title":"Eur J Clin Microbiot Infect Dis"},{"key":"10.4065\/74.1.78_bib184","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM197007302830503","article-title":"Treatment of chronic pulmonary histoplasmosis: a National Communicable Disease Center Cooperative Mycoses Study","volume":"283","author":"Parker","year":"1970","journal-title":"N Engl J Med"},{"issue":"Suppl l","key":"10.4065\/74.1.78_bib185","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/clinids\/19.Supplement_1.S19","article-title":"Histoplasmosis: recognition and treatment","volume":"19","author":"Wheat","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib186","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9343(99)80311-8","article-title":"Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome","volume":"98","author":"Wheat","year":"1995","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib187","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/arrd.1969.100.3.314","article-title":"The treatment of North American blastomycosis: ten years' experience","volume":"100","author":"Lockwood","year":"1969","journal-title":"Am Rev Respir Dis"},{"key":"10.4065\/74.1.78_bib188","first-page":"208","article-title":"Amphotericin therapy of North American blastomycosis","volume":"6","author":"Abernathy","year":"1966","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib189","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/26.4.561","article-title":"Adverse events associated with itraconazole in 189 patients on chronic therapy","volume":"26","author":"Tucker","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.1.78_bib190","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM198602273140901","article-title":"Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin","volume":"314","author":"Klein","year":"1986","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.4065\/74.1.78_bib191","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/clinids\/22.Supplement_2.S102","article-title":"Histoplasmosis and olastomycosis","volume":"22","author":"Bradsher","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib192","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00005792-199309000-00003","article-title":"Blastomycosis in immunocompromised patients","volume":"72","author":"Pappas","year":"1993","journal-title":"Medicine"},{"key":"10.4065\/74.1.78_bib193","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1439-0507.1988.tb03653.x","article-title":"The treatment of aspergillosis and aspergilloma with itraconazole. clinical results of an open international study (1982 1987)","volume":"31","author":"De Beule","year":"1988","journal-title":"Mycoses"},{"key":"10.4065\/74.1.78_bib194","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0190-9622(90)70263-H","article-title":"Itraconazole therapy in aspergillosis: study in 49 pa tients","volume":"23","author":"Dupont","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/74.1.78_bib195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4065\/71.1.25","article-title":"Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy","volume":"71","author":"Caras","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/74.1.78_bib196","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0163-4453(89)91178-X","article-title":"Experience with itraconazole in cryptococcosis and aspergillosis","volume":"18","author":"Viviani","year":"1989","journal-title":"J infect"},{"key":"10.4065\/74.1.78_bib197","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1378\/chest.100.3.813","article-title":"Adjunctive therapy of allergie bronchopulmonary aspergillosis with itraconazole","volume":"100","author":"Denning","year":"1991","journal-title":"Chest"},{"key":"10.4065\/74.1.78_bib198","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1378\/chest.107.3.883","article-title":"Allergie bronchopulmonary aspergillosis treated with itraconazole [letter]","volume":"107","author":"Germaud","year":"1995","journal-title":"Chest"},{"key":"10.4065\/74.1.78_bib199","first-page":"LB","article-title":"Randomized double-blind study of itraconazole (IZ) in allergic bronchopulmonary aspergillosis (ABPA] [abstract]","volume":"37","author":"Stevens","year":"1997","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib200","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/clinids\/12.6.1147","article-title":"Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases [published erratum appears in Rev infect Dis 1991:13:345]","volume":"12","author":"Denning","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib201","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1093\/clinids\/19.Supplement_1.S41","article-title":"Invasive aspergillosis in patients with AIDS","volume":"19","author":"Khoo","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0002-9343(94)90023-X","article-title":"NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis","volume":"97","author":"Denning","year":"1994","journal-title":"4m J Med"},{"key":"10.4065\/74.1.78_bib203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0190-9622(90)70260-O","article-title":"European experience with itraconazole in systemic mycoses","volume":"23","author":"Vivianl","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/74.1.78_bib204","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1439-0507.1988.tb03986.x","article-title":"Oral itraconazole therapy for mycotic keratitis","volume":"31","author":"Thomas","year":"1988","journal-title":"Mycoses"},{"key":"10.4065\/74.1.78_bib205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0163-4453(91)90954-Q","article-title":"The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B","volume":"22","author":"van't Wout","year":"1991","journal-title":"J Infect"},{"key":"10.4065\/74.1.78_bib206","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1439-0507.1991.tb00800.x","article-title":"Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis","volume":"34","author":"Kreisel","year":"1991","journal-title":"Mycoses"},{"key":"10.4065\/74.1.78_bib207","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/archinte.1997.00440370097010","article-title":"Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria","volume":"157","author":"Stevens","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.1.78_bib208","doi-asserted-by":"crossref","first-page":"14851487","DOI":"10.1093\/clinids\/21.6.1485","article-title":"Treatment of cerebral aspergillosis with itraconazole: do high doses improve the prognosis?","volume":"21","author":"Sanchez","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib209","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/archinte.1989.00390100107024","article-title":"Itraconazole therapy for cryptDcoccal meningitis and cryptococcosis","volume":"149","author":"Denning","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.1.78_bib210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-199202000-00007","article-title":"Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis","volume":"6","author":"de Gans","year":"1992","journal-title":"AIDS"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib211","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000239048","article-title":"US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host","volume":"38","author":"Hostetler","year":"1992","journal-title":"Chemotherapy"},{"key":"10.4065\/74.1.78_bib212","first-page":"253","article-title":"Treatment of cryptococcal meningi tis with combination itraconazole and flucytosine","volume":"77","author":"Chotmongkol","year":"1994","journal-title":"J Med Assoc Thai"},{"key":"10.4065\/74.1.78_bib213","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1439-0507.1993.tb00755.x","article-title":"Cryptococcal meningitis: the place of itraconazole","volume":"36","author":"Cauwenbergh","year":"1993","journal-title":"Mycoses"},{"key":"10.4065\/74.1.78_bib214","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/00002030-199409000-00008","article-title":"Pulmonary cryptococcosis associated with HIV-1 infection in Rwanda: a retrospective study of 37 cases","volume":"8","author":"Batungwanayo","year":"1994","journal-title":"AIDS"},{"key":"10.4065\/74.1.78_bib215","doi-asserted-by":"crossref","first-page":"451470","DOI":"10.1111\/j.1749-6632.1988.tb40443.x","article-title":"Treatment of mycoses with itraconazole","volume":"544","author":"Tucker","year":"1988","journal-title":"Ann NY Acad Sci"},{"key":"10.4065\/74.1.78_bib216","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0002-9343(90)90339-F","article-title":"Itraconazole treatment of coccidioidomycosis","volume":"89","author":"Graybill","year":"1990","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib217","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1378\/chest.100.3.682","article-title":"Itraconazole in the treatment of coccidioidomycosis","volume":"100","author":"Diaz","year":"1991","journal-title":"Chest"},{"key":"10.4065\/74.1.78_bib218","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-112-2-108","article-title":"Itraconazole therapy for chronic coccidioidal meningitis","volume":"112","author":"Tucker","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib219","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0190-9622(90)70256-H","article-title":"Treatment of oral candidosis with itraconazole: a review","volume":"23","author":"Blatchford","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/74.1.78_bib220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/AAC.37.1.89","article-title":"Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis","volume":"37","author":"Stein","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib221","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/JCM.32.9.2092-2098.1994","article-title":"Emergence of fluconazoleresistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection","volume":"32","author":"Ruhnke","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.4065\/74.1.78_bib222","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00002030-199610000-00009","article-title":"Itraconazole cyelodextrm solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility","volume":"10","author":"Phillips","year":"1996","journal-title":"AIDS"},{"key":"10.4065\/74.1.78_bib223","unstructured":"Fessel WJ, Merrill KW, Ward D, Moskovltz B, Benken C, Oleka N, et al. Itraconazole oral solution (IS) for the treatment of fluconazole-refractory oropharyngeal candidiasis (OC) in HIVpositive patients [abstract]. In: Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic infections; 1997 Jan 22-26; Washington (DC). p124"},{"key":"10.4065\/74.1.78_bib224","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/514028","article-title":"A randomized, double blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis","volume":"176","author":"Wllcox","year":"1997","journal-title":"J Infect Dis"},{"key":"10.4065\/74.1.78_bib225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01719497","article-title":"Efficacy of itraconazole in treating AIDS-associ-ated infections due to Candida krusei","volume":"11","author":"Coppola","year":"1995","journal-title":"Eur J Epidemiol"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib226","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/clinids\/9.Supplement_1.S47","article-title":"Oral treatment of paracoccidioidomycosis and histoplasmosis with itraconazole in humans","volume":"9","author":"Negroni","year":"1987","journal-title":"Rev infect Dis"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib227","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/clinids\/9.Supplement_1.S51","article-title":"Itraconazole in the treatment of paracoccidioidomycosis: a preliminary report","volume":"9","author":"Restrepo","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib228","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/02681219080000091","article-title":"Treatment of paracoccidioidomycosis with itraconazote","volume":"28","author":"Naranjo","year":"1990","journal-title":"J Med Vet Mycol"},{"key":"10.4065\/74.1.78_bib229","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1749-6632.1988.tb40448.x","article-title":"Treat ment of chromoblastomycosis with itraconazole","volume":"544","author":"Restrepo","year":"1988","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib230","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/clinids\/9.Supplement_1.S57","article-title":"A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis","volume":"9","author":"Borelli","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib231","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1128\/AAC.37.11.2407","article-title":"Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium mameffei infections and in vitro susceptibilities of isolates from clinical specimens","volume":"37","author":"Supparatpinyo","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib232","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clind\/16.6.803","article-title":"Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole","volume":"16","author":"Goldberg","year":"1993","journal-title":"On Infect Dis"},{"key":"10.4065\/74.1.78_bib233","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/clind\/16.5.731","article-title":"Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report [letter]","volume":"16","author":"Nomdedeu","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib234","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF01967593","article-title":"Successful treatment of pulmonary pseudallescheriasis with itraconazole [letter]","volume":"12","author":"Stolk-Engelaar","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.1.78_bib235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0163-4453(92)91799-H","article-title":"Acute pyogenic Pseudallescheria boydii foot infection sequentially treated with miconazole and itraconazole [letter]","volume":"25","author":"Pettier","year":"1992","journal-title":"J Infect"},{"key":"10.4065\/74.1.78_bib236","first-page":"674","article-title":"Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole","volume":"9","author":"Piper","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/74.1.78_bib237","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-4362.1994.tb01049.x","article-title":"Treatment of cutaneous leishmaniasis with oral itraconazole","volume":"33","author":"Van den Enden","year":"1994","journal-title":"Int J Dermatoi"},{"key":"10.4065\/74.1.78_bib238","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archderm.1995.01690150124031","article-title":"Itraconazole therapy for human immunodeficiency virus-associated eosinophilic folliculitis [letter]","volume":"131","author":"Berger","year":"1995","journal-title":"Arch Dermatol"},{"issue":"Suppl 11","key":"10.4065\/74.1.78_bib239","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1439-0507.1989.tb02299.x","article-title":"Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels","volume":"32","author":"Boogaerts","year":"1989","journal-title":"Mycoses"},{"key":"10.4065\/74.1.78_bib240","first-page":"84","article-title":"Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients","volume":"39","author":"Thunnissen","year":"1991","journal-title":"Neth J Med"},{"key":"10.4065\/74.1.78_bib241","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10428199309067926","article-title":"Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologie malignancres and intensive chemotherapy: a double blind, placebo controlled study","volume":"11","author":"Vreugdenhll","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/74.1.78_bib242","first-page":"286","article-title":"Itraconazole (IT) oral solution vs fluconazole (F) suspension for antifungal prophylaxis in neutropenic patients [abstract]","volume":"36","author":"Morgenstern","year":"1996","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib243","first-page":"380","article-title":"Antifungal prophylaxis in neutropenic pts (<1000\/mmc) with haematologic malignancy: a double-blind trial to compare itraconazole oral solution (I0S) with placebo (PLA) [abstract]","volume":"37","author":"Del Favero","year":"1997","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib244","unstructured":"Cauwenbergh G, Legend R, Blatchford N. Itraconazole a novel oral antifungal: its efficacy and safety profile. Presented at the 8th Regional Conference of Dermatology; 1988 Jun 16-20; Bali (Indonesia)"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib245","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1093\/clinids\/9.Supplement_1.S64","article-title":"Itraconazole for deep mycoses: preliminary experience in Mexico","volume":"9","author":"Lavalle","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib246","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2133.1993.tb03186.x","article-title":"Itraconazole-induced acute hepatitis [letter]","volume":"129","author":"Hann","year":"1993","journal-title":"Br J Dermatoi"},{"key":"10.4065\/74.1.78_bib247","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0140-6736(92)90527-A","article-title":"Hepatic injury associated with itraconazole [letter]","volume":"340","author":"Lavrijsen","year":"1992","journal-title":"Lancet"},{"key":"10.4065\/74.1.78_bib248","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/AAC.35.4.707","article-title":"High-dose itraconazole in the treatment of severe mycoses","volume":"35","author":"Sharkey","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.4065\/74.1.78_bib249","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/clinids\/9.Supplement_1.S43","article-title":"Itraconazole: pharmacologie studies in animals and humans","volume":"9","author":"Van Cauteren","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.1.78_bib250","first-page":"210","article-title":"Itraconazole (I) therapy (Rx) for blastomycosis (B) histoplasmosis (H) and sporotrichosis (S) [abstract]","volume":"28","author":"Saag","year":"1988","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.1.78_bib251","series-title":"Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents","first-page":"263","article-title":"The toxicological properties of itraconazole","author":"Van Cauteren","year":"1987"},{"key":"10.4065\/74.1.78_bib252","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(93)90317-I","article-title":"Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine","volume":"95","author":"Crane","year":"1993","journal-title":"Am J Med"},{"key":"10.4065\/74.1.78_bib253","series-title":"Important safety information","year":"1995"},{"key":"10.4065\/74.1.78_bib254","first-page":"920921","article-title":"Itraconazole and cyclosporin nephrotoxicity [letter]","volume":"2","author":"Nov\u00b4kov\u00b4","year":"1987","journal-title":"Lancet"},{"key":"10.4065\/74.1.78_bib255","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0140-6736(87)90873-7","article-title":"Interaction of cyclosporin and itraconazole [letter]","volume":"2","author":"Kwan","year":"1987","journal-title":"Lancet"},{"key":"10.4065\/74.1.78_bib256","doi-asserted-by":"crossref","first-page":"327","DOI":"10.7326\/0003-4819-113-4-327","article-title":"Cyclosporine and itraconazole interaction in heart and lung transplant recipients","volume":"113","author":"Kramer","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib257","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-116-6-525","article-title":"Itraconazole-digoxin interaction [letter]","volume":"116","author":"Rex","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib258","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/clind\/16.3.400","article-title":"Interaction of itraconazole and digoxin","volume":"16","author":"Sachs","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib259","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJM199509073331015","article-title":"Rhabdomyolysis from the coadrninistration of lovastatin and the antifungal agent itraconazole [letter]","volume":"333","author":"Lees","year":"1995","journal-title":"N Engl J Med"},{"key":"10.4065\/74.1.78_bib260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0190-9622(95)90040-3","article-title":"Itraconazole interacts with felodipine","volume":"33","author":"Neuvonen","year":"1995","journal-title":"J Am Acad Dermatoi"},{"key":"10.4065\/74.1.78_bib261","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-125-11-199612010-00021","article-title":"Uveitis associated with rifabutin prophylaxis and itraconazole therapy [letter]","volume":"125","author":"Lefort","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.1.78_bib262","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/clinids\/18.2.266","article-title":"Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole [letter]","volume":"18","author":"Drayton","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib263","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/14.1.165","article-title":"Interaction of azoles with rifampin, phenytoin. and carbamazepine: in vitro and clinical observations","volume":"14","author":"Tucker","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.1.78_bib264","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1001\/jama.1993.03500120046022","article-title":"Itraconazole didanosine excipient interaction [letter]","volume":"269","author":"Moreno","year":"1993","journal-title":"JAMA"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611645655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611645655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T01:11:00Z","timestamp":1589505060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611645655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":264,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["S0025619611645655"],"URL":"https:\/\/doi.org\/10.4065\/74.1.78","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}